Wed, Nov 04, 2026 - Page 33
24697 indexed SquawkNews stories from this UTC day. Showing 3841-3960.
L
AtriCure Form 144 Filed by Salvatore Privitera
A Form 144 for AtriCure was filed by Salvatore Privitera.
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
Scage Future files Form 6-K
Scage Future filed a Form 6-K on November 4.
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
Park-Ohio Holdings Reports Third-Quarter Net Income of $13.7 Million
EARNINGS | Nov 04, 2026, 09:10 PM UTC
L
NeoVolta Form 4 Filed by John A. Hass
A Form 4 for NeoVolta Inc. was filed by John A. Hass. The filing lists November 10; the body says it was filed November 4.
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
Warrior Met Coal Reports Third-Quarter Net Income of $49.3 Million
EARNINGS | Nov 04, 2026, 09:10 PM UTC
L
Vertex, Inc. files Form 8-K
Vertex, Inc. filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:10 PM UTC
M
Klaviyo Sees FY Revenue at $425M–$1.54B
EARNINGS | Nov 04, 2026, 09:10 PM UTC
L
Grand Canyon Education files Form 8-K
Grand Canyon Education filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:10 PM UTC
M
Innoviva Reports Third-Quarter Revenue of $106.1 Million
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
Goldman Sachs and Apollo in talks to sell SpaceX’s $40 billion AI deal $GS $SPCX
Goldman Sachs and Apollo in talks to sell SpaceX’s $40 billion AI deal $GS $SPCX
NEWS | Nov 04, 2026, 09:10 PM UTC
M
MGIC Investment Reports Q3 2026 Net Income of $175 Million
MGIC reported third-quarter 2026 net income of $175.0 million, or $0.85 per diluted share.
EARNINGS | Nov 04, 2026, 09:10 PM UTC
M
Innoviva Reports Third-Quarter Loss of $1.03 Per Share
EQUITY | Nov 04, 2026, 09:10 PM UTC
H
Expedia earnings above expectations at 9.39 USD
Expedia (EXPE) released earnings per share at 9.39 USD, compared to market expectations of 8.44 USD.
EARNINGS | Nov 04, 2026, 09:10 PM UTC
L
Baird Medical Issues Statement on Recent Share Price Volatility
Baird Medical said it provided a statement regarding recent volatility in its market price. The supplied text does not include the statement’s details.
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
e.l.f. Beauty Reports $520.8M in Second-Quarter Sales
e.l.f. Beauty reported second-quarter sales of $520.8 million.
EARNINGS | Nov 04, 2026, 09:10 PM UTC
M
AMSC Reports Fiscal Q2 Revenue of $94.0 Million, Expects Q3 Above $80 Million
AMSC reported fiscal Q2 revenue of $94.0 million, up from $65.9 million a year earlier. Net income was $3.0 million versus $4.8 million. The company expects Q3 revenue above $80.0 million and net income above breakeven.
EQUITY | Nov 04, 2026, 09:10 PM UTC
M
Nature’s Sunshine Cuts 2026 Sales and EBITDA Outlook
Q3 2026 net sales fell 9% to $116.6 million, while diluted EPS declined to $0.11 from $0.30 year over year. The company lowered 2026 net sales guidance to $460 million–$470 million from $490 million–$500 million and adju
EARNINGS | Nov 04, 2026, 09:10 PM UTC
L
FatPipe Files Form 10-Q for September 30
FatPipe filed a Form 10-Q for the period ended September 30.
EQUITY | Nov 04, 2026, 09:10 PM UTC
L
e.l.f. Beauty Reports 2Q EPS
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
71 West Capital Partners Files Form 13F-HR
The filing covers the period ended September 30.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Precigen Reports Third-Quarter 2026 Results
Precigen reported third-quarter 2026 results, highlighting sequential PAPZIMEOS revenue growth and positive cash flow ahead of guidance.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
e.l.f. Beauty Reports Second-Quarter Adjusted EPS of $1.21
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
e.l.f. Beauty 2Q Net Income $30M
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
IDEXX Laboratories Form 144 Filed by Michael Lane
A Form 144 was filed for IDEXX Laboratories by Michael Lane.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Runway Growth Finance Declares Fourth-Quarter 2026 Dividend of $0.33 per Share
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Netgear Reports Third-Quarter Revenue of $167.3 Million
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Vertex Raises Full-Year 2026 Revenue and Adjusted EBITDA Outlook
Vertex reported Q3 2026 results and raised its full-year revenue and Adjusted EBITDA outlook. The release provided no figures for the results or revised outlook.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Nature's Sunshine Reports Third-Quarter Net Income of $1.89 Million
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
Evolus Reports Q3 Revenue Growth and Positive Adjusted EBITDA
Evolus reported 13% year-over-year revenue growth and its fourth consecutive quarter of positive adjusted EBITDA. The company reaffirmed its full-year 2026 financial outlook.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Freshworks
BlackRock filed a Schedule 13G/A related to Freshworks Inc.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Resideo to Participate in Upcoming Investor Conferences
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Netgear Reports $12.3 Million Third-Quarter Loss
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Netgear reports third-quarter adjusted EPS
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
HMH Reports Third-Quarter 2026 Revenue of $171.1 Million, Down 21%
HMH Holding reported third-quarter 2026 revenue of $171.1 million, down 21%.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Amplitude Reports Third-Quarter 2026 Financial Results
Amplitude announced results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Tenaya Therapeutics Reports Third-Quarter 2026 Results and Business Update
Tenaya Therapeutics said it received FDA Regenerative Medicine Advanced Therapy designation for TN-401.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Mohawk Industries
BlackRock filed a Schedule 13G/A for Mohawk Industries on November 4.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for AvePoint
BlackRock filed a Schedule 13G/A for AvePoint, Inc.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Aflac Announces Third-Quarter 2026 Results and Fourth-Quarter Dividend
Aflac reported its third-quarter 2026 results and declared a fourth-quarter dividend.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Arbor Realty Trust
BlackRock filed an amended Schedule 13G for Arbor Realty Trust. The filing date shown is November 4, though the year is truncated.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Revolution Medicines Reports Third-Quarter 2026 Financial Results
Revolution Medicines announced its third-quarter 2026 financial results. The supplied body provides no figures.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Larimar Therapeutics to Participate in Healthcare Innovation Conference
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Corteva
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Relay Therapeutics reports third-quarter loss per share
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Alamar Biosciences to Participate in Investor Conferences
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
HubSpot reports third-quarter net income of $83 million
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Wingstop
BlackRock filed a Schedule 13G/A for Wingstop Inc.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Relay Therapeutics Reports Third-Quarter 2026 Results and Corporate Updates
The company said enrollment in its Phase 3 ReDiscover-2 trial is expected to finish in mid-year. Updated data from its ReInspire trial is slated for presentation at the 68th ASH Annual Meeting.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
HubSpot reports third-quarter revenue of $947.6 million
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Silvaco Expects 35% Sequential Q4 Revenue Growth
Silvaco forecasts 17% year-over-year revenue growth in 2026 at the midpoint of its guided range, with mid-to-high teens growth expected in 2027.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
ThredUp Reports Third-Quarter 2026 Results
ThredUp reported quarterly revenue of $88.2 million, up 7% year over year.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Amended Schedule 13G for Olin
BlackRock filed an amended Schedule 13G concerning Olin Corp.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Veracyte Reports Q3 2026 Revenue Growth, Announces $100 Million Buyback
Total revenue reached $151.8 million and testing revenue was $146.4 million, up 15% year over year. Veracyte also announced a $100 million share repurchase program.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Safety Insurance Announces Third-Quarter Results and Fourth-Quarter Dividend
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Upland Software Reports Third-Quarter 2026 Financial Results
Upland Software announced its third-quarter 2026 results, outlined a multi-year strategic plan and issued fourth-quarter and full-year 2026 guidance.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Gevo
A Schedule 13G/A for Gevo was filed by BlackRock. The filing date shown is November 4, but the year is incomplete.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
HubSpot reports third-quarter EPS of $1.67
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
Interparfums Reports Third-Quarter Net Income of $68M
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
HubSpot reports third-quarter adjusted EPS of $3.81
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Franklin BSP Realty Trust
BlackRock filed a Schedule 13G/A related to Franklin BSP Realty Trust. The filing date is shown as November 4, but the year is incomplete.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
PROCEPT BioRobotics Reports Q3 2026 Results, Reaffirms Guidance
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Encore Capital Group Reports Third-Quarter 2026 Financial Results
Encore Capital Group reported consolidated financial results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Workiva
BlackRock filed a Schedule 13G/A for Workiva. The filing date is shown as November 4, 20.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
AMSC Reports Second Quarter Fiscal Year 2026 Financial Results and Business Outlook
Second Quarter Financial Highlights:Company to host conference call tomorrow, November 5th, at 10:00 am ETAYER, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- AMSC NASDAQ:AMSC, a leading provider of power control solutions tha
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Nasdaq Reports October 2026 Trading Volumes
Nasdaq said it posted October 2026 monthly volume data on its investor relations website.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Matrix Service Returns to Profit With $6.2M Q1 Net Income
Matrix reported Q1 FY2027 revenue of $219.4 million, up from $211.9 million a year earlier, and net income of $6.2 million versus a $3.7 million loss. Its board approved a new $25 million share buyback program.
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
Mainstay Income Opportun files Form D
A Form D filing for Mainstay Income Opportun is dated November 4.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Medicus Pharma Schedules Third-Quarter 2026 Business Update Call for November 9
The call’s planned highlights include the company’s strategy for entering a CD228V co-development and licensing agreement and a proposed SkinJect business combination with concurrent financing.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
ThredUp Reports Third-Quarter 2026 Results and Updates Outlook
ThredUp announced financial results for the quarter ended September 30, 2026, and updated its financial outlook.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
OnKure Reports $163.3 Million in Cash, Runway Into 2029
OnKure reported $163.3 million in cash, cash equivalents and marketable securities as of September 30, 2026, which it expects to fund operations into 2029. Q3 net loss was $17.8 million, or $0.36 per share, compared with
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
AdaptHealth to Participate in Investor Conference
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
LeMaitre Vascular Reports Third-Quarter Sales of $68M
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
Interparfums Reports Q3 Results, Raises Full-Year Sales Guidance
Third-quarter net sales were $430 million and diluted EPS was $2.13. The company also reported nine-month results and reaffirmed its earnings outlook.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Ascent Industries Q3 Sales Rise 37.8% to $27.1 Million
Net sales from continuing operations increased year over year from $19.7 million to $27.1 million. Net income was $1.4 million, versus a $0.1 million loss, while adjusted EBITDA rose 155.8% to $3.5 million.
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
LeMaitre Vascular Reports Third-Quarter Net Income of $15 Million
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G for Navient Holdings
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Great Elm Group Reports Fiscal 2027 First-Quarter Results
Great Elm Group reported fiscal 2027 first-quarter financial results and highlighted strategic initiatives across credit and real estate, more than $43 million in cash and cash equivalents, and acquisition activity by Mo
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
XBP Global Schedules Call on Third-Quarter 2026 Results
XBP Global scheduled a conference call to discuss its third-quarter 2026 financial results.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
New Zealand Three-Month Budget Deficit NZ$2.82B; NZ$1.32B Narrower Than Forecast
New Zealand Three-Month Budget Deficit NZ$2.82B; NZ$1.32B Narrower Than Forecast
NEWS | Nov 04, 2026, 09:09 PM UTC
M
Coherent Reports $2.37B Q1 Revenue, Expects FY27 Growth Above 60%
Coherent said Q1 fiscal 2027 pro forma revenue rose 56% year over year and non-GAAP EPS increased 80%. It expects a first quarter with non-GAAP gross margin above 45% before the end of calendar 2028.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Ormat Technologies reports third-quarter EPS
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
Nature's Sunshine Reports Third-Quarter 2026 Results
Nature’s Sunshine Products reported results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Schrodinger reports third-quarter loss per share
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Paymentus to Participate in Upcoming Investor Conferences
EQUITY | Nov 04, 2026, 09:09 PM UTC
H
Interparfums, Inc. Reports 2026 Third Quarter and Nine-Month Results; Raises Full Year Sales Guidance and Reaffirms Earnings Outlook
Third Quarter Net Sales of $430 Million with Diluted EPS of $2.13; Nine-Month Sales Increased to $1.1 Billion with Diluted EPS of $4.43Quarterly Cash Dividend of $0.80 Per Share to be Paid on December 31, 2026NEW YORK, N
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
Schrodinger Reports 3Q Revenue of $64.5M
EARNINGS | Nov 04, 2026, 09:09 PM UTC
M
U.S. Stocks Rally as Dow Gains 3.0% and S&P 500 Rises 1.8%
As of 2:31 p.m. ET, the Dow was up 1,552.12 points, or 3.0%, at 53,338.84; the S&P 500 gained 1.8% to 7,702.43.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Pattern Reports Record Q3 2026 Financial Results
Pattern reported Q3 revenue growth of 38%, with revenue of $886 million. Net revenue retention was 127%, up from 122% in the prior-year period.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Cytek Q3 Revenue Rises 2% to $53.2M; Narrows 2026 Outlook Range
Q3 2026 revenue increased 2% year over year to $53.2 million. Cytek reported a $6.1 million net loss, compared with $5.5 million, and maintained its full-year revenue midpoint while narrowing its range to $208 million–$2
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Lesaka Delivers Q1 FY2027 Results, Reaffirms Guidance
Lesaka Technologies released its first-quarter fiscal 2027 results, said they were in line with expectations, and reaffirmed its fiscal 2027 guidance.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
KORU Medical to Participate in Upcoming Investor Conferences
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Mineralys Therapeutics Reports Third-Quarter 2026 Results and Update
The company says commercialization plans for lorundrostat are on track ahead of a December 22 PDUFA target date.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
AppLovin Reports Third-Quarter Net Income of $1.44 Billion
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
AppLovin Reports Third-Quarter EPS of $4.30
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
Medicus Pharma to Host Third-Quarter 2026 Business Update Call November 9
Medicus Pharma says it will host a call on November 9, 2026, to discuss third-quarter financial performance and provide a business update.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
AppLovin Reports Third-Quarter Revenue of $2.18B
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics announced an inducement grant approved by its board compensation committee.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for Wyndham Hotels & Resorts
A Schedule 13G/A for Wyndham Hotels & Resorts was filed by BlackRock, Inc.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
EverQuote to Present at Upcoming Investor Conferences
EverQuote said management will present and hold one-on-one investor meetings at upcoming conferences.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
QIAGEN Reports Q3 2026 Results, Sales Rise 3% to $548 Million
QIAGEN said third-quarter sales and adjusted diluted EPS were ahead of its outlook, in line with preliminary results. Sales rose 3% year over year to $548 million.
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Coherent Reports First-Quarter Fiscal 2027 Results
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
EverQuote to Present at Upcoming Investor Conferences
EQUITY | Nov 04, 2026, 09:09 PM UTC
M
Lyell Immunopharma Reports Third-Quarter 2026 Financial Results
Lyell Immunopharma reported third-quarter 2026 financial results and business highlights.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Titan America SA (TTAM) Expects 2026 EBITDA Margin to Fall 250—300 Bps YoY
Q3 revenue rose 5.7% to $461.6M, including approximately $30M from Keystone; net income fell to $39.8M from $57.4M and Adjusted EBITDA to $95.0M from $116.7M. Titan expects mid-single-digit 2026 revenue growth and an app
EARNINGS | Nov 04, 2026, 09:09 PM UTC
L
BlackRock Files Schedule 13G/A for BioMarin Pharmaceutical
BlackRock filed a Schedule 13G/A for BioMarin Pharmaceutical. The filing date is truncated in the source.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Polar Power Says It Has Made No Roth Facility Sales Since Oct. 19
Polar Power disclosed historical equity-line-of-credit issuances and said it does not currently intend to issue additional shares at valuations it considers excessively dilutive.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Fastly Says Go-to-Market President Scott Lovett Plans to Retire in 2027
Fastly says it is beginning a search for a chief revenue officer.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Boost Run Sets Date for Third-Quarter 2026 Results Call
Boost Run announced the date of its third-quarter 2026 financial results conference call.
EQUITY | Nov 04, 2026, 09:09 PM UTC
L
Alamar Biosciences to Participate in Upcoming Investor Conferences
Alamar Biosciences announced it will participate in upcoming investor conferences.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
BlackRock Files Schedule 13G for MSG Rangers Corp.
BlackRock filed a Schedule 13G for MSG Rangers Corp. The filing date is listed as November 4, 20.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Rapid7 Announces Third-Quarter 2026 Financial Results
Rapid7 announced its financial results for the third quarter of 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Matrix Service Reports 1Q Net Income of $6.19M
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
electroCore Reports Third-Quarter 2026 Net Sales of $9.7 Million
Third-quarter 2026 net sales were $9.7 million, up 12% from $8.7 million in the year-earlier quarter.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Cytek Biosciences Reports Third-Quarter 2026 Financial Results
Cytek Biosciences reported financial results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Blue Owl Technology Finance Announces Third-Quarter 2026 Results
The company announced financial results for the quarter ended September 30, 2026. It described earnings as steady and NAV as rebounding.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Pega to Present at Upcoming Investor Conference
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
AppLovin Reports Record Third-Quarter 2026 Earnings
AppLovin said net income grew 72% year over year to $1.44 billion.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Matrix Service reports first-quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Kailera Reports Third-Quarter 2026 Financial Results
Kailera Therapeutics reported financial results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Acadia Healthcare Reports Third-Quarter Net Income of $34.5M
EARNINGS | Nov 04, 2026, 09:08 PM UTC